Story · Medicine & Biotech

In T2D inadequately controlled with metformin, orforglipron reduced HbA1c more than dapagliflozin at 40 wk

1 outlet · first reported by Annals of Internal Medicine 8d ago

Coverage, in order

  1. 8d ago
    Annals of Internal Medicine indie study peer-reviewed
    In T2D inadequately controlled with metformin, orforglipron reduced HbA1c more than dapagliflozin at 40 wk

    Annals of Internal Medicine, Ahead of Print.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.